Publications

Becker Kerstin, Lange Jens, von Stockum Sophia, Serrani Marco, Heinemann Klaas, Long-term treatment of endometriosis with dienogest: Real-world results from the VIPOS study Journal of Endometriosis and Pelvic Pain Disorders. 2021; 10.1177/2284026521993688.

Barnett Clare, Bauerfeind Anja, von Stockum Sophia, Heinemann Klaas, Thromboembolic safety profile of low-dose estradiol (valerate) in combined hormonal preparations: Implications for the development of new hormonal endometriosis and uterine fibroid therapies Journal of Endometriosis and Pelvic Pain Disorders. 2021; 1 - 10. 10.1177/22840265211019546.

Becker Kerstin, Lange Jens, von Stockum Sophia, Heinemann Klaas, Risk of depression and anemia in users of hormonal endometriosis treatments: Results from the VIPOS study European Journal of Obstetrics &Gynecology and Reproductive Biology. 2020; 212 - 217. 10.1016/j.ejogrb.2020.05.049.

Dinger Jürgen, COCs containing dienogest and 30 μg ethinylestradiol may carry a higher VTE risk compared to corresponding preparations with levonorgestrel: A meta-analysis of four large cohort studies. Frontiers in Women's Health. 2020; Vol. 5: 1-6. 10.15761/FWH.1000175.
Download PDF: Jürgen-2020_COCs-containing-dienogest-and-30-μg-ethinylestradiol.pdf

Dinger Jürgen, Heinemann Klaas, Combined oral contraceptives containing dienogest and estradiol valerate may carry a lower risk of venous and arterial thromboembolism compared to conventional preparations: Results from the extended INAS-SCORE study. Frontiers in Women's Health. 2020; Vol. 5: 1-8. 10.15761/FWH.1000178.
Download PDF: Jürgen-et-al.-2020_Results-from-the-extended-INAS-SCORE-study.pdf

Barnett Clare, Bauerfeind Anja, von Stockum Sophia, Grimes David A., Heinemann Klaas, Comparing the Cardiovascular Risk of Norethindrone Acetate & Levonorgestrel Pills: Is There a Difference? [10I]. Obstetrics & Gynecology. 2020; Volume 135 - Issue - p 94S. 10.1097/01.AOG.0000664136.96902.7e.

Bögemann Martin, Zagorska Aleksandra, Akumo Divine, El Hadad Laila, Pignot Marc, Using Data from a Sickness Fund Claims Database to Assess the Treatment Patterns and Healthcare Resource Utilization among Patients with Metastatic Renal Cell Carcinoma in Germany Urologia Internationalis. 2020; 10.1159/000509973.

Ständer Sonja, Ketz Miriam, Kossack Nils, Akumo Divine, Pignot Marc, Gabriel Sylvie, Chavda Rajeev, Epidemiology of Prurigo Nodularis compared with Psoriasis in Germany: A Claims Database Analysis. Acta Dermato-Venereologica. 2020; 100 (18): adv00309. 10.2340/00015555-3655.

Heinemann Klaas, Imthurn Bruno, Marions Lena, Gerlinger Christoph, Becker Kerstin, Faustmann Thomas, Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study Advances in Therapy. 2020; 2528-2537. 10.1007/s12325-020-01331-z.

Do Minh Thai, Lange Jens, Koro Carol, Fox Michelle, Heinemann Klaas, Real world data on Nexplanon® procedure-related events: final results from the Nexplanon observational risk assessment study (NORA) Contraception. 2019; pii: S0010-7824(19)30131-3. 10.1016/j.contraception.2019.03.052.

Barnett Clare, Dinger Jürgen, Do Minh Thai, Heinemann Klaas, Unintended pregnancy rates differ according to combined oral contraceptive – results from the INAS-SCORE study Contraception & Reproductive Health Care. 2019; 1-4. 10.1080/13625187.2019.1629412.

Barnett Clare, Do Minh Thai, Heinemann Klaas, Perforation risk and intra-uterine devices: results of the EURAS-IUD 5-year extension study The European Journal of Contraception and Reproductive Health Care. 2018; page 1-5.

Heinemann Klaas, Barnett Clare, Do Minh Thai, IUD use among parous women and risk of uterine perforation: a secondary analysis Contraception. 2017; Volume 95, Issue 6, Pages 605–607.

Heinemann Klaas, Pauls Karl, Drug Utilization Study on the Prescribing Indications for CPA/EE (Cyproterone acetate 2mg in combination with Ethinylestradiol 35mcg) in 5 European Countries Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue S2, Pages 1-674.

Heinemann Klaas, Safety and efficacy of intrauterine devices: Baseline characteristics of 32,022 study participants from the EURAS-LCS12 study Pharmacoepidemiology and Drug Safety. 2017; Volume 26, Issue Supplement S2 Pages 1–674.